Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Accutar, Actinogen Medical, Alterity, Ascletis, Beigene, Biontech, Bio-Thera Solutions, Hutchmed, Junshi, Moleculin, Novavax, Nuance, Pfizer, Verona.